First Time Loading...

Repare Therapeutics Inc
NASDAQ:RPTX

Watchlist Manager
Repare Therapeutics Inc Logo
Repare Therapeutics Inc
NASDAQ:RPTX
Watchlist
Price: 3.15 USD -4.55% Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

RPTX Price Targets Summary
Repare Therapeutics Inc

Wall Street analysts forecast RPTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RPTX is 18.02 USD with a low forecast of 8.08 USD and a high forecast of 30.45 USD.

RPTX Lowest Forecast
Wall Street Target
8.08 USD
157% Upside
RPTX Average Forecast
Wall Street Target
18.02 USD
472% Upside
RPTX Highest Forecast
Wall Street Target
30.45 USD
867% Upside
Lowest
Price Target
8.08 USD
157% Upside
Average
Price Target
18.02 USD
472% Upside
Highest
Price Target
30.45 USD
867% Upside

RPTX Last Price Targets
Repare Therapeutics Inc

The latest public price target was made on Feb 3, 2023 by Unknown Analyst from Morgan Stanley , who expects RPTX stock to rise by 376% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
Morgan Stanley
15 USD
Upside 376%
1 year ago
Feb 3, 2023
Morgan Stanley Downgrades Repare Therapeutics to Equal-Weight, Lowers Price Target to $15
Benzinga
Unknown Analyst
Morgan Stanley
Price Target 15 USD
Upside/Downside 376%
View Source
Repare Therapeutics Inc Competitors:
Price Targets
DSGN
Design Therapeutics Inc
29% Upside
NBIX
Neurocrine Biosciences Inc
13% Upside
B
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
195% Upside
VIR
Vir Biotechnology Inc
332% Upside
DSGN
Design Therapeutics Inc
29% Upside
NBIX
Neurocrine Biosciences Inc
13% Upside
B
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
195% Upside
VIR
Vir Biotechnology Inc
332% Upside
DNLI
Denali Therapeutics Inc
181% Upside
SERA
Sera Prognostics Inc
73% Downside
ZYME
Zymeworks Inc
84% Upside
ELYM
Eliem Therapeutics Inc
33% Upside

Revenue
Forecast

Revenue Estimate
Repare Therapeutics Inc

The compound annual growth rate of Repare Therapeutics Inc's revenue for the next 3 years is -13%.

N/A
Past Growth
-13%
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Repare Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Repare Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
RPTX intrinsic value, competitors valuation, and company profile.
DCF Valuation
RPTX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
RPTX stock valuation using valuation multiples.
Wall Street Estimates
RPTX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
RPTX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RPTX's stock price target?
Price Target
18.02 USD

According to Wall Street analysts, the average 1-year price target for RPTX is 18.02 USD with a low forecast of 8.08 USD and a high forecast of 30.45 USD.

What is Repare Therapeutics Inc's Revenue forecast?
Projected CAGR
-13%

The compound annual growth rate of Repare Therapeutics Inc's revenue for the next 3 years is -13%.

ALPHA SPREAD
Join more than 131,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.